Zoom Logo

Q&A with DHS and MDH - Shared screen with speaker view
Amanda Tamte
06:43
Good morning!
Jill Slaikeu
11:44
sorry i was late!
Joe Peterson
17:03
Question about EVV- many EVV vendors that track the geographical location/Geo-fencing recognize the person's home as the only allowable place to provide service. Many people who receive HCBS services like IHSwT receive services both at home and in their community. My question is can services be provided throughout a person's community if tracked by GPS?
ARRM Admin
18:14
Everyone, please enter your questions into the Q&A feature on the screen
Doug Annett
21:44
Here is the process to access BinaxNOW tests: https://www.health.state.mn.us/diseases/coronavirus/hcp/binaxnow.html . The order form link is near the bottom of the web page.
JP Mahoehney
22:06
Some Testing OptionsVault at home test kits:https://www.health.state.mn.us/diseases/coronavirus/testsites/athome.htmlNo cost community testing sites:https://mn.gov/covid19/get-tested/testing-locations/index.jspState BinaxNow Antigen kits (these come with a number of requirements to use them):https://www.health.state.mn.us/diseases/coronavirus/hcp/binaxnow.html
Sarah Schultz
31:16
We know that some of the services that are in-scope for EVV are sometimes provided remotely. When that is recognized as a distinct procedure code with modifiers, as it is with Individualized Home Supports, the remote service is not in-scope for EVV. Only in-home Individualized Home Supports are required to use EVV.However, when the service doesn’t have a distinct procedure code for the remote version of that support, we need a different approach. For example, PCA supervision provided by a Qualified Professional. We’re working with HHAX on how to handle that scenario when sometimes the service is provided in-person and sometimes it is provided remotely but there is no distinction in how the service is billed.
JP Mahoehney
32:23
3rd Dose Vaccine info:https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fclinical-considerations.htmlImmunocompromised info:https://wwwnc.cdc.gov/travel/yellowbook/2020/travelers-with-additional-considerations/immunocompromised-travelersA patient’s clinical team is best positioned to determine the degree of immune compromise and appropriate timing of vaccination.
JP Mahoehney
34:18
Use of Antigen Testshttps://www.health.state.mn.us/diseases/coronavirus/hcp/ltcantigentest.pdf does a good job of guiding settings through the proper uses of antigen tests, particularly the questions that ask when it is appropriate to use Antigen tests and when it is not appropriate to use antigen tests.
JP Mahoehney
43:33
https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
JP Mahoehney
45:01
https://www.health.state.mn.us/communities/ep/surge/crisis/ppegrid.pdf
JP Mahoehney
45:47
https://www.cdc.gov/vaccines/pandemic-guidance/index.html
JP Mahoehney
47:21
I am so sorry that I was disconnected. Not sure where it cut off.
Amanda Tamte
53:55
DHS.128@state.mn.us for EVV questions
JP Mahoehney
58:19
Hi Kim, in relation to your question this resource may be appropriate: https://www.eeoc.gov/wysk/what-you-should-know-about-covid-19-and-ada-rehabilitation-act-and-other-eeo-laws
Amanda Tamte
01:13:00
Thank you everyone for your time today!